Science Explorer Back to mapMap
Discussion
Institution · Caris Life Sciences (United States)

Most cited papers from Caris Life Sciences (United States)

Caris Life Sciences (United States)

What are the most cited papers from Caris Life Sciences (United States)?

The most cited paper from Caris Life Sciences (United States) is "Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade" (Dung Thi Le et al., 2017), with 6,813 citations. Next come "Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function" (1,679) and "Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study" (1,110).

Showing 50 of 60 papers. Every paper with more than 107 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Dung Thi Le et al. · Science Open access 27 Jul 2017 6,813
2 Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function Torsten Olszak, Dingding An, Sebastian Zeißig et al. · Science Open access 23 Mar 2012 1,679
3 Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al. · The Lancet Mar 2011 1,110
4 Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal Ino de Bruijn et al. · Cancer Research Open access 5 Sep 2023 918
5 Changes in circulating microRNA levels associated with prostate cancer Richard J. Bryant, Traci L. Pawlowski, James W.F. Catto et al. · British Journal of Cancer Open access 12 Jan 2012 719
6 Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type Zoran Gatalica, Carrie Snyder, Todd Maney et al. · Cancer Epidemiology Biomarkers & Prevention 12 Nov 2014 533
7 Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project Diana M. Merino et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2020 516
8 HER2 expression status in diverse cancers: review of results from 37,992 patients Min Yan, Maria Clemence Schwaederle, David Arguello et al. · Cancer and Metastasis Reviews ReviewOpen access 24 Feb 2015 501
9 Molecular characterization of cancers with NTRK gene fusions Zoran Gatalica, Joanne Xiu, Jeffrey J. Swensen et al. · Modern Pathology Open access 31 Aug 2018 498
10 Microsatellite instability status determined by next‐generation sequencing and compared with PD ‐L1 and tumor mutational burden in 11,348 patients Ari M. Vanderwalde, David B. Spetzler, Nianqing Xiao et al. · Cancer Medicine Open access 13 Feb 2018 477
11 Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy Tiffany R. Hodges, Martina Ott, Joanne Xiu et al. · Neuro-Oncology Open access 15 Feb 2017 428
12 A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors Sandip Pravin Patel et al. · Clinical Cancer Research Open access 22 Jan 2020 343
13 NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019 Deborah Kay Armstrong et al. · Journal of the National Comprehensive Cancer Network Open access Aug 2019 334
14 Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients Richard H. Lash, Robert Maximilian Genta, Christopher M. Schuler · Journal of Clinical Pathology 14 Jun 2010 334
15 Outcomes of COVID-19 in patients with CLL: a multicenter international experience Anthony R. Mato et al. · Blood Open access 20 Jul 2020 320
16 Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors Sherri Z. Millis, Sadakatsu Ikeda, Sandeep Bobby Reddy et al. · JAMA Oncology Open access 7 Jul 2016 316
17 Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC Andrew T. Gabrielson et al. · Cancer Immunology Research Open access 11 Mar 2016 316
18 Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer John H. Strickler, Jonathan M. Loree, Leanne G. Ahronian et al. · Cancer Discovery Open access Dec 2017 312
19 Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity Yuanjiu Lei et al. · Cell Open access 22 Jun 2023 289
20 Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood Amy J. Sehnert, Brian K. Rhees, David Comstock et al. · Clinical Chemistry 26 Apr 2011 289
21 Detection of NRG1 Gene Fusions in Solid Tumors Sushma Jonna, Rebecca A. Feldman, Jeffrey J. Swensen et al. · Clinical Cancer Research Open access 15 Apr 2019 236
22 Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma Vasiliki Panou et al. · Journal of Clinical Oncology Open access 16 Aug 2018 232
23 Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers Mohamed E. Salem, Alberto Puccini, Axel F. Grothey et al. · Molecular Cancer Research Open access 9 Mar 2018 224
24 Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers Mohamed E. Salem, Benjamin Adam Weinberg, Joanne Xiu et al. · Oncotarget Open access 21 Sep 2017 221
25 A National Study of Helicobactor pylori Infection in Gastric Biopsy Specimens Amnon Sonnenberg, Richard H. Lash, Robert Maximilian Genta · Gastroenterology 24 Aug 2010 214
26 Adherence to biopsy guidelines increases celiac disease diagnosis Benjamin Lebwohl, Robert C. Kapel, Alfred I. Neugut et al. · Gastrointestinal Endoscopy Open access 23 May 2011 204
27 PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation Richard Wayne Joseph, Sherri Z. Millis, Estrella M. Carballido et al. · Cancer Immunology Research Open access 25 Aug 2015 199
28 Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer Julia Judd et al. · Molecular Cancer Therapeutics Open access 13 Sep 2021 197
29 Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma Mohamed E. Salem, Alberto Puccini, Joanne Xiu et al. · The Oncologist Open access 4 Jun 2018 197
30 Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets Benjamin Adam Weinberg, Joanne Xiu, Michael R. Lindberg et al. · Journal of Gastrointestinal Oncology Open access 9 Jul 2019 187
31 Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content Thida Lwin, Shelby D. Melton, Robert M. Genta · Modern Pathology Open access 17 Dec 2010 187
32 Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma Philip A. Philip, Ibrahim Azar, Joanne Xiu et al. · Clinical Cancer Research Open access 18 Mar 2022 186
33 Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project Diana Merino Vega et al. · Annals of Oncology Open access Oct 2021 186
34 Automated real-world data integration improves cancer outcome prediction Justin Jee et al. · Nature Open access 6 Nov 2024 182
35 Inverse Association of Esophageal Eosinophilia With Helicobacter pylori Based on Analysis of a US Pathology Database Evan S. Dellon, Anne F. Peery, Nicholas J. Shaheen et al. · Gastroenterology Open access 22 Jul 2011 177
36 Relationship between MLH1 , PMS2 , MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors Mohamed E. Salem, Joseph Nicholas Bodor, Alberto Puccini et al. · International Journal of Cancer Open access 25 May 2020 172
37 Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital Rajal B. Shah, Jeffrey Scott Montgomery, James E. Montie et al. · Urologic Oncology Seminars and Original Investigations 3 Jul 2012 172
38 PD-L1 status in breast cancer: Current view and perspectives Semir Vranić, Farhan Sachal Cyprian, Zoran Gatalica et al. · Seminars in Cancer Biology 26 Dec 2019 159
39 Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition S M NAZMUL HAQUE, Robert Maximilian Genta · Gut 9 Dec 2011 147
40 High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine Zoran Gatalica, Semir Vranić, Joanne Xiu et al. · Familial Cancer Open access 13 Feb 2016 146
41 Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer Kristi Baker, Timo Räth, Magdalena B. Flak et al. · Immunity Open access 27 Nov 2013 142
42 Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma June YiJuan Hou, Caitlin D. Baptiste, Radhika Bangalore Hombalegowda et al. · Cancer Open access 27 Dec 2016 140
43 Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies Sarah T. Garber, Yuuri Hashimoto, Shiao-Pei Weathers et al. · Neuro-Oncology Open access Jul 2016 140
44 Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database Jeff Owsley, Matthew K. Stein, Jason Porter et al. · Experimental Biology and Medicine Open access 5 Oct 2020 133
45 Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1 Upasana Joneja, Semir Vranić, Jeffrey J. Swensen et al. · Journal of Clinical Pathology Open access 16 Aug 2016 133
46 No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients Robert Maximilian Genta, Christopher M. Schuler, Cristian Robiou et al. · Clinical Gastroenterology and Hepatology 23 May 2009 133
47 TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations Jason O'Rawe et al. · The American Journal of Human Genetics Open access Dec 2015 131
48 Histopathologic Diagnosis of Eosinophilic Conditions in the Gastrointestinal Tract Jennifer M. Hurrell, Robert M. Genta, Shelby D. Melton · Advances in Anatomic Pathology Sep 2011 131
49 Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets Sujana Movva, Wenhsiang Wen, Wangjuh Chen et al. · Oncotarget Open access 26 Mar 2015 131
50 Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects Line Merethe Myklebust, Petra Van Damme, Svein Isungset Støve et al. · Human Molecular Genetics Open access 8 Dec 2014 129

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.